|
|
|
Upsher-Smith Launches Nyamyc™ (Nystatin Topical Powder, USP)
Maple Grove MN, May 3, 2005—Upsher-Smith Laboratories, Inc. has received approval from the FDA
to market
Nyamyc™ (Nystatin Topical Powder, USP). Nyamyc™ Powder is an economical
brand
of nystatin powder indicated for the treatment of cutaneous or mucocutaneous
mycotic
infections.
NyamycTM Powder is an AT Rated, low-cost alternative to the brand
name product,
Mycostatin®*. Nyamyc™ Powder is available 15 gram
and 30 gram bottles and will be
supported by promotional programs targeting physicians and pharmacists.
Nyamyc™ Powder expands the Upsher-Smith line, which includes
other dermatological
products as well as cardiovascular products and a wide array of
generics. For more
information and full prescribing information, visit www.upsher-smith.com or
call 1-800- 654-2299.
Upsher-Smith Laboratories,
Inc. is a fully integrated pharmaceutical company that manufactures
and markets prescription pharmaceutical, OTC, and cosmetic products.
Upsher-Smith is also actively involved in licensing innovative compounds
that are in clinical development. For more information about Upsher-Smith
Laboratories, Inc., call 1-800-654-2299 or visit www.upsher-smith.com.
* Mycostatin is a registered trademark of Westwood Squibb Pharmaceuticals,
Inc.
Please See Full Prescribing Information
NY06A.05050
|
